GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: ALD-1910 | ALD1910 | LU AG-09222 | Lu AG09222 | Lu-AG09222 | LuAG09222
Compound class:
Antibody
Comment: Bocunebart (Lu AG09222 from Lundbeck; formerly ALD1910) is a humanized monoclonal antibody that targets both isoforms of PACAP (PACAP-27 and PACAP-38) [1-2]. It is designed to disrupt PACAP signaling via its receptors as a mechanism to reduce migraine episodes [2-3]. The PACAP epitope engaged by Lu AG09222 is nonlinear, with interactions at amino acids in positions 19, 22, 23, and/or 27 required for potent binding.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13356 | bocunebart |
Synonyms ![]() |
| ALD-1910 | ALD1910 | LU AG-09222 | Lu AG09222 | Lu-AG09222 | LuAG09222 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1747 |
| Other databases | |
| Search PubMed clinical trials | bocunebart |
| Search PubMed titles | bocunebart |
| Search PubMed titles/abstracts | bocunebart |